KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Free Cash Flow (2017 - 2025)

Historic Free Cash Flow for Guardant Health (GH) over the last 9 years, with Q3 2025 value amounting to -$45.8 million.

  • Guardant Health's Free Cash Flow rose 1718.3% to -$45.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$262.2 million, marking a year-over-year increase of 442.01%. This contributed to the annual value of -$274.9 million for FY2024, which is 2041.27% up from last year.
  • According to the latest figures from Q3 2025, Guardant Health's Free Cash Flow is -$45.8 million, which was up 1718.3% from -$65.9 million recorded in Q2 2025.
  • In the past 5 years, Guardant Health's Free Cash Flow registered a high of -$25.9 million during Q1 2021, and its lowest value of -$135.0 million during Q2 2022.
  • For the 5-year period, Guardant Health's Free Cash Flow averaged around -$77.4 million, with its median value being -$81.3 million (2021).
  • In the last 5 years, Guardant Health's Free Cash Flow crashed by 32198.06% in 2021 and then surged by 5486.37% in 2024.
  • Over the past 5 years, Guardant Health's Free Cash Flow (Quarter) stood at -$101.6 million in 2021, then increased by 0.85% to -$100.8 million in 2022, then rose by 17.81% to -$82.8 million in 2023, then fell by 0.7% to -$83.4 million in 2024, then surged by 45.12% to -$45.8 million in 2025.
  • Its Free Cash Flow was -$45.8 million in Q3 2025, compared to -$65.9 million in Q2 2025 and -$67.1 million in Q1 2025.